IP Library Granted Patent US 10,232,156
Granted Patent B2
US 10,232,156 · App. 15/699,382 · Granted Mar 19, 2019

Drug delivery methods and systems

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,232,156
App. No.
15/699,382
Granted
Mar 19, 2019
Kind
B2
Abstract

A two-part bioactive agent delivery system, the system including a disposable part comprising an agent reservoir, a bolus chamber, the volume of the bolus chamber being less than the volume of the agent reservoir, an agent outlet, and a valve having a first position communicating the agent reservoir with the bolus chamber and a second position communicating the bolus chamber with the outlet; and a reusable part including a valve driver, a power source and control electronics, the control electronics being adapted to control the valve driver to actuate the valve to deliver bioactive agent from the agent reservoir to the agent outlet; the system further having a spring extending between the agent reservoir piston and a surface of the reusable part or of the disposable part to pressurize the agent reservoir when the spring is compressed and the agent reservoir contains a quantity of bioactive agent.

Claims (23)

1. A two-part bioactive agent delivery system, the two-part bioactive agent delivery system comprising:

a disposable part comprising

an agent reservoir, the agent reservoir comprising a piston movably disposed in a chamber,

a bolus chamber, the bolus chamber comprising a piston movably disposed in a chamber, the volume of the bolus chamber being less than the volume of the agent reservoir,

an agent outlet communicating with the bolus chamber to receive a bioactive agent dissolved in a solvent from the bolus chamber, and

a valve having a first position communicating the agent reservoir with the bolus chamber and a second position communicating the bolus chamber with the agent outlet; and

a reusable part comprising a valve driver, a power source and control electronics, the control electronics being adapted to control the valve driver to actuate the valve to deliver the bioactive agent from the agent reservoir to the agent outlet;

a first spring extending between the agent reservoir piston and a surface to pressurize the agent reservoir when the first spring is compressed and the agent reservoir contains a quantity of the bioactive agent; and

a second spring extending between the bolus chamber piston and a surface, the second spring being at least partially loaded when a quantity of the bioactive agent is present in the bolus chamber.

2. The two-part bioactive agent delivery system of claim 1 further comprising a transdermal patch communicating with the outlet and adapted to transdermally deliver the bioactive agent to a user.

3. The two-part bioactive agent delivery system of claim 2 further comprising a solvent recovery chamber disposed in the disposable part and communicating with the transdermal patch, the solvent recovery chamber being adapted to receive gaseous phase solvent from the transdermal patch, and a desiccant or absorbent material disposed in the solvent recovery chamber.

4. The two-part bioactive agent delivery system of claim 3 further comprising a vapor permeable membrane in the disposable part adjacent to the transdermal patch and in fluid communication with the solvent recovery chamber.

5. The two-part bioactive agent delivery system of claim 4 wherein the agent outlet is configured to provide the bioactive agent dissolved in the solvent to a space between the transdermal patch and the vapor permeable membrane.

6. The two-part bioactive agent delivery system of claim 2 wherein the transdermal patch comprises a polypropylene membrane.

7. The two-part bioactive agent delivery system of claim 6 wherein the polypropylene membrane has pores with an average pore diameter of about 0.02 μm to about 0.10 μm.

8. The two-part bioactive agent delivery system of claim 1 wherein the first spring wherein the spring is disposed in the disposable part prior to connecting the disposable part to the reusable part.

9. The two-part bioactive agent delivery system of claim 1 wherein the first spring wherein the spring is disposed in the reusable part prior to connecting the disposable part to the reusable part.

10. The two-part bioactive agent delivery system of claim 1 wherein the second spring extends between the bolus chamber piston and a surface in the disposable part, the bolus chamber piston being adapted to move and load the second spring when pressurized bioactive agent enters the bolus chamber from the agent reservoir through the valve.

11. The two-part bioactive agent delivery system of claim 1 wherein the second spring extends between the bolus chamber piston and a surface in the reusable part.

12. The two-part bioactive agent delivery system of claim 1 wherein the valve is a rotatable valve having a range of motion between 60° to 90°, inclusive.

13. The two-part bioactive agent delivery system of claim 1 wherein the surface comprises a surface in the reusable part, the first spring becoming at least partially loaded when the disposable part is connected to the reusable part and the agent reservoir contains a quantity of the bioactive agent.

14. The two-part bioactive agent delivery system of claim 1 wherein the agent reservoir and bolus chamber are configured to contain a bioactive agent and a solvent solution comprising alcohol and water, wherein the solvent solution has a ratio of water to alcohol of about 40:60 to about 60:40.

15. The two-part bioactive agent delivery system of claim 1 further comprising a connection indicator operatively connected to the control electronics to provide an indication that the reusable part has been connected to the disposable part.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2021
From: CTI (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC
To: MORNINGSIDE VENTURE INVESTMENTS LIMITED
Reel/Frame 055382/0388 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2021
From: CHRONO THERAPEUTICS, INC.
To: CTI (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC
Reel/Frame 055384/0227 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2019
From: NETZEL, ZITA S.; STACEY, GARY; NORMAN, ALEXANDER DAVID; HUANG, CONGYI; FREARSON, TIMOTHY CHARLES; KILBY, CHARLES FRAZER; RUANE, PATRICK H.; LEVY, ALAN J.; GELSTON, KEVIN W.; DARMOUR, JENNIFER; HAPGOOD, JENNY E.; ROTH, DAVID EVANS; OVERBECK, RONALD A.; TONG, LING-KANG
To: CHRONO THERAPEUTICS INC.
Reel/Frame 048144/0076 →
Cited By (5)
US 12,376,802 US 12,397,141 US 12,515,030 US 12,629,503 US 12,649,029